This is the third randomized trial in recent years to show that a proton-pump inhibitor (PPI) conferred no clinically important improvement in asthma control for patients with both asthma and GERD.

Her son had asthma his whole life, and had two asthma pumps in his gym locker, she said. But then she received a call from her husband who had been called by the coach asking if Xavier ever had ...

412 adults with inadequately controlled asthma were randomized to receive the proton-pump inhibitor (PPI) esomeprazole (Nexium; 40 mg twice daily) or placebo. Reasoning that patients who have ...